XML 49 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions and divestitures - Narrative: Acquisition of ChemoCentryx Inc (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Oct. 20, 2022
Sep. 30, 2023
Dec. 31, 2022
Business Acquisition [Line Items]      
Goodwill   $ 15,509 $ 15,529
ChemoCentryx, Inc.      
Business Acquisition [Line Items]      
Business acquisition, share price (in dollars per share) $ 52.00    
Business asset acquisition, consideration transferred $ 3,900    
Goodwill increase (decrease)   (18)  
Cash payment 3,700    
Business acquisition, cash consideration paid to equity holders for pre-acquisition services $ 181    
Finite-lived intangible assets—developed-product-technology rights   3,499  
Inventories   $ 41  
Business combination, turnover period of inventory acquired   13 months  
Deferred tax liability   $ 502  
Goodwill   649  
ChemoCentryx, Inc. | Developed Technology Rights      
Business Acquisition [Line Items]      
Finite-lived intangible assets—developed-product-technology rights   $ 3,500  
Weighted average period of amortization   11 years